世界のIV＆経口鉄剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global IV and Oral Iron Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5812
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、124ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、IV＆経口鉄剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口鉄薬、IV鉄剤）、用途別市場規模（腎臓、OBGYN、手術、胃腸病、腫瘍、心不全（HF））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・IV＆経口鉄剤の市場動向
・企業の競争状況、市場シェア
・IV＆経口鉄剤の種類別市場規模と予測2016-2027（経口鉄薬、IV鉄剤）
・IV＆経口鉄剤の用途別市場規模と予測2016-2027（腎臓、OBGYN、手術、胃腸病、腫瘍、心不全（HF））
・IV＆経口鉄剤の北米市場規模2016-2027（アメリカ、カナダ）
・IV＆経口鉄剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・IV＆経口鉄剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・IV＆経口鉄剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・IV＆経口鉄剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Daiichi Sankyo Company、Vifor Pharma、Akebia Therapeutics、Allergan、AMAG Pharmaceuticals、AOP Orphan Pharmaceuticals、Pharmacosmos、Sanofi、Shield Therapeutics、AZAD Pharma、Cirondrugs、MEDICE、Pfizer、Salveo Lifecare、Sunny Pharmaceutical）
・結論

Market Analysis and Insights: Global IV and Oral Iron Drugs Market
The global IV and Oral Iron Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IV and Oral Iron Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IV and Oral Iron Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IV and Oral Iron Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IV and Oral Iron Drugs market.

Global IV and Oral Iron Drugs Scope and Market Size
IV and Oral Iron Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IV and Oral Iron Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Iron Drug
IVIron Drugs

Segment by Application
Nephrology
OBGYN
Surgeries
Gastroenterology
Oncology
Heart failure (HF)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Daiichi Sankyo Company
Vifor Pharma
Akebia Therapeutics
Allergan
AMAG Pharmaceuticals
AOP Orphan Pharmaceuticals
Pharmacosmos
Sanofi
Shield Therapeutics
AZAD Pharma
Cirondrugs
MEDICE
Pfizer
Salveo Lifecare
Sunny Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Iron Drug
1.2.3 IVIron Drugs
1.3 Market by Application
1.3.1 Global IV and Oral Iron Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Nephrology
1.3.3 OBGYN
1.3.4 Surgeries
1.3.5 Gastroenterology
1.3.6 Oncology
1.3.7 Heart failure (HF)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global IV and Oral Iron Drugs Market Perspective (2016-2027)
2.2 IV and Oral Iron Drugs Growth Trends by Regions
2.2.1 IV and Oral Iron Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IV and Oral Iron Drugs Historic Market Share by Regions (2016-2021)
2.2.3 IV and Oral Iron Drugs Forecasted Market Size by Regions (2022-2027)
2.3 IV and Oral Iron Drugs Industry Dynamic
2.3.1 IV and Oral Iron Drugs Market Trends
2.3.2 IV and Oral Iron Drugs Market Drivers
2.3.3 IV and Oral Iron Drugs Market Challenges
2.3.4 IV and Oral Iron Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top IV and Oral Iron Drugs Players by Revenue
3.1.1 Global Top IV and Oral Iron Drugs Players by Revenue (2016-2021)
3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by Players (2016-2021)
3.2 Global IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IV and Oral Iron Drugs Revenue
3.4 Global IV and Oral Iron Drugs Market Concentration Ratio
3.4.1 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IV and Oral Iron Drugs Revenue in 2020
3.5 IV and Oral Iron Drugs Key Players Head office and Area Served
3.6 Key Players IV and Oral Iron Drugs Product Solution and Service
3.7 Date of Enter into IV and Oral Iron Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 IV and Oral Iron Drugs Breakdown Data by Type
4.1 Global IV and Oral Iron Drugs Historic Market Size by Type (2016-2021)
4.2 Global IV and Oral Iron Drugs Forecasted Market Size by Type (2022-2027)

5 IV and Oral Iron Drugs Breakdown Data by Application
5.1 Global IV and Oral Iron Drugs Historic Market Size by Application (2016-2021)
5.2 Global IV and Oral Iron Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America IV and Oral Iron Drugs Market Size (2016-2027)
6.2 North America IV and Oral Iron Drugs Market Size by Type
6.2.1 North America IV and Oral Iron Drugs Market Size by Type (2016-2021)
6.2.2 North America IV and Oral Iron Drugs Market Size by Type (2022-2027)
6.2.3 North America IV and Oral Iron Drugs Market Size by Type (2016-2027)
6.3 North America IV and Oral Iron Drugs Market Size by Application
6.3.1 North America IV and Oral Iron Drugs Market Size by Application (2016-2021)
6.3.2 North America IV and Oral Iron Drugs Market Size by Application (2022-2027)
6.3.3 North America IV and Oral Iron Drugs Market Size by Application (2016-2027)
6.4 North America IV and Oral Iron Drugs Market Size by Country
6.4.1 North America IV and Oral Iron Drugs Market Size by Country (2016-2021)
6.4.2 North America IV and Oral Iron Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe IV and Oral Iron Drugs Market Size (2016-2027)
7.2 Europe IV and Oral Iron Drugs Market Size by Type
7.2.1 Europe IV and Oral Iron Drugs Market Size by Type (2016-2021)
7.2.2 Europe IV and Oral Iron Drugs Market Size by Type (2022-2027)
7.2.3 Europe IV and Oral Iron Drugs Market Size by Type (2016-2027)
7.3 Europe IV and Oral Iron Drugs Market Size by Application
7.3.1 Europe IV and Oral Iron Drugs Market Size by Application (2016-2021)
7.3.2 Europe IV and Oral Iron Drugs Market Size by Application (2022-2027)
7.3.3 Europe IV and Oral Iron Drugs Market Size by Application (2016-2027)
7.4 Europe IV and Oral Iron Drugs Market Size by Country
7.4.1 Europe IV and Oral Iron Drugs Market Size by Country (2016-2021)
7.4.2 Europe IV and Oral Iron Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific IV and Oral Iron Drugs Market Size (2016-2027)
8.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Type
8.2.1 Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Application
8.3.1 Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific IV and Oral Iron Drugs Market Size by Region
8.4.1 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America IV and Oral Iron Drugs Market Size (2016-2027)
9.2 Latin America IV and Oral Iron Drugs Market Size by Type
9.2.1 Latin America IV and Oral Iron Drugs Market Size by Type (2016-2021)
9.2.2 Latin America IV and Oral Iron Drugs Market Size by Type (2022-2027)
9.2.3 Latin America IV and Oral Iron Drugs Market Size by Type (2016-2027)
9.3 Latin America IV and Oral Iron Drugs Market Size by Application
9.3.1 Latin America IV and Oral Iron Drugs Market Size by Application (2016-2021)
9.3.2 Latin America IV and Oral Iron Drugs Market Size by Application (2022-2027)
9.3.3 Latin America IV and Oral Iron Drugs Market Size by Application (2016-2027)
9.4 Latin America IV and Oral Iron Drugs Market Size by Country
9.4.1 Latin America IV and Oral Iron Drugs Market Size by Country (2016-2021)
9.4.2 Latin America IV and Oral Iron Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa IV and Oral Iron Drugs Market Size (2016-2027)
10.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Type
10.2.1 Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Application
10.3.1 Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa IV and Oral Iron Drugs Market Size by Country
10.4.1 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Details
11.1.2 Daiichi Sankyo Company Business Overview
11.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Introduction
11.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.1.5 Daiichi Sankyo Company Recent Development
11.2 Vifor Pharma
11.2.1 Vifor Pharma Company Details
11.2.2 Vifor Pharma Business Overview
11.2.3 Vifor Pharma IV and Oral Iron Drugs Introduction
11.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.2.5 Vifor Pharma Recent Development
11.3 Akebia Therapeutics
11.3.1 Akebia Therapeutics Company Details
11.3.2 Akebia Therapeutics Business Overview
11.3.3 Akebia Therapeutics IV and Oral Iron Drugs Introduction
11.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.3.5 Akebia Therapeutics Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan IV and Oral Iron Drugs Introduction
11.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 AMAG Pharmaceuticals
11.5.1 AMAG Pharmaceuticals Company Details
11.5.2 AMAG Pharmaceuticals Business Overview
11.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Introduction
11.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.5.5 AMAG Pharmaceuticals Recent Development
11.6 AOP Orphan Pharmaceuticals
11.6.1 AOP Orphan Pharmaceuticals Company Details
11.6.2 AOP Orphan Pharmaceuticals Business Overview
11.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Introduction
11.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.6.5 AOP Orphan Pharmaceuticals Recent Development
11.7 Pharmacosmos
11.7.1 Pharmacosmos Company Details
11.7.2 Pharmacosmos Business Overview
11.7.3 Pharmacosmos IV and Oral Iron Drugs Introduction
11.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.7.5 Pharmacosmos Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi IV and Oral Iron Drugs Introduction
11.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Shield Therapeutics
11.9.1 Shield Therapeutics Company Details
11.9.2 Shield Therapeutics Business Overview
11.9.3 Shield Therapeutics IV and Oral Iron Drugs Introduction
11.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.9.5 Shield Therapeutics Recent Development
11.10 AZAD Pharma
11.10.1 AZAD Pharma Company Details
11.10.2 AZAD Pharma Business Overview
11.10.3 AZAD Pharma IV and Oral Iron Drugs Introduction
11.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.10.5 AZAD Pharma Recent Development
11.11 Cirondrugs
11.11.1 Cirondrugs Company Details
11.11.2 Cirondrugs Business Overview
11.11.3 Cirondrugs IV and Oral Iron Drugs Introduction
11.11.4 Cirondrugs Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.11.5 Cirondrugs Recent Development
11.12 MEDICE
11.12.1 MEDICE Company Details
11.12.2 MEDICE Business Overview
11.12.3 MEDICE IV and Oral Iron Drugs Introduction
11.12.4 MEDICE Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.12.5 MEDICE Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer IV and Oral Iron Drugs Introduction
11.13.4 Pfizer Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.13.5 Pfizer Recent Development
11.14 Salveo Lifecare
11.14.1 Salveo Lifecare Company Details
11.14.2 Salveo Lifecare Business Overview
11.14.3 Salveo Lifecare IV and Oral Iron Drugs Introduction
11.14.4 Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.14.5 Salveo Lifecare Recent Development
11.15 Sunny Pharmaceutical
11.15.1 Sunny Pharmaceutical Company Details
11.15.2 Sunny Pharmaceutical Business Overview
11.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Introduction
11.15.4 Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2016-2021)
11.15.5 Sunny Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global IV and Oral Iron Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Iron Drug
Table 3. Key Players of IVIron Drugs
Table 4. Global IV and Oral Iron Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global IV and Oral Iron Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global IV and Oral Iron Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global IV and Oral Iron Drugs Market Share by Regions (2016-2021)
Table 8. Global IV and Oral Iron Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global IV and Oral Iron Drugs Market Share by Regions (2022-2027)
Table 10. IV and Oral Iron Drugs Market Trends
Table 11. IV and Oral Iron Drugs Market Drivers
Table 12. IV and Oral Iron Drugs Market Challenges
Table 13. IV and Oral Iron Drugs Market Restraints
Table 14. Global IV and Oral Iron Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global IV and Oral Iron Drugs Market Share by Players (2016-2021)
Table 16. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IV and Oral Iron Drugs as of 2020)
Table 17. Ranking of Global Top IV and Oral Iron Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by IV and Oral Iron Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players IV and Oral Iron Drugs Product Solution and Service
Table 21. Date of Enter into IV and Oral Iron Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IV and Oral Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global IV and Oral Iron Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global IV and Oral Iron Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global IV and Oral Iron Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global IV and Oral Iron Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global IV and Oral Iron Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global IV and Oral Iron Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global IV and Oral Iron Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America IV and Oral Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America IV and Oral Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America IV and Oral Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America IV and Oral Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America IV and Oral Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America IV and Oral Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe IV and Oral Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe IV and Oral Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe IV and Oral Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe IV and Oral Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe IV and Oral Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe IV and Oral Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America IV and Oral Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America IV and Oral Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America IV and Oral Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America IV and Oral Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America IV and Oral Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America IV and Oral Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Daiichi Sankyo Company Company Details
Table 62. Daiichi Sankyo Company Business Overview
Table 63. Daiichi Sankyo Company IV and Oral Iron Drugs Product
Table 64. Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 65. Daiichi Sankyo Company Recent Development
Table 66. Vifor Pharma Company Details
Table 67. Vifor Pharma Business Overview
Table 68. Vifor Pharma IV and Oral Iron Drugs Product
Table 69. Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 70. Vifor Pharma Recent Development
Table 71. Akebia Therapeutics Company Details
Table 72. Akebia Therapeutics Business Overview
Table 73. Akebia Therapeutics IV and Oral Iron Drugs Product
Table 74. Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 75. Akebia Therapeutics Recent Development
Table 76. Allergan Company Details
Table 77. Allergan Business Overview
Table 78. Allergan IV and Oral Iron Drugs Product
Table 79. Allergan Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 80. Allergan Recent Development
Table 81. AMAG Pharmaceuticals Company Details
Table 82. AMAG Pharmaceuticals Business Overview
Table 83. AMAG Pharmaceuticals IV and Oral Iron Drugs Product
Table 84. AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 85. AMAG Pharmaceuticals Recent Development
Table 86. AOP Orphan Pharmaceuticals Company Details
Table 87. AOP Orphan Pharmaceuticals Business Overview
Table 88. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product
Table 89. AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 90. AOP Orphan Pharmaceuticals Recent Development
Table 91. Pharmacosmos Company Details
Table 92. Pharmacosmos Business Overview
Table 93. Pharmacosmos IV and Oral Iron Drugs Product
Table 94. Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 95. Pharmacosmos Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Shield Therapeutics Company Details
Table 101. Shield Therapeutics Business Overview
Table 102. Shield Therapeutics IV and Oral Iron Drugs Product
Table 103. Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 104. Shield Therapeutics Recent Development
Table 105. AZAD Pharma Company Details
Table 106. AZAD Pharma Business Overview
Table 107. AZAD Pharma IV and Oral Iron Drugs Product
Table 108. AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 109. AZAD Pharma Recent Development
Table 110. Cirondrugs Company Details
Table 111. Cirondrugs Business Overview
Table 112. Cirondrugs IV and Oral Iron Drugs Product
Table 113. Cirondrugs Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 114. Cirondrugs Recent Development
Table 115. MEDICE Company Details
Table 116. MEDICE Business Overview
Table 117. MEDICE IV and Oral Iron Drugs Product
Table 118. MEDICE Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 119. MEDICE Recent Development
Table 120. Pfizer Company Details
Table 121. Pfizer Business Overview
Table 122. Pfizer IV and Oral Iron Drugs Product
Table 123. Pfizer Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 124. Pfizer Recent Development
Table 125. Salveo Lifecare Company Details
Table 126. Salveo Lifecare Business Overview
Table 127. Salveo Lifecare IV and Oral Iron Drugs Product
Table 128. Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 129. Salveo Lifecare Recent Development
Table 130. Sunny Pharmaceutical Company Details
Table 131. Sunny Pharmaceutical Business Overview
Table 132. Sunny Pharmaceutical IV and Oral Iron Drugs Product
Table 133. Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2016-2021) & (US$ Million)
Table 134. Sunny Pharmaceutical Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IV and Oral Iron Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Iron Drug Features
Figure 3. IVIron Drugs Features
Figure 4. Global IV and Oral Iron Drugs Market Share by Application: 2020 VS 2027
Figure 5. Nephrology Case Studies
Figure 6. OBGYN Case Studies
Figure 7. Surgeries Case Studies
Figure 8. Gastroenterology Case Studies
Figure 9. Oncology Case Studies
Figure 10. Heart failure (HF) Case Studies
Figure 11. IV and Oral Iron Drugs Report Years Considered
Figure 12. Global IV and Oral Iron Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global IV and Oral Iron Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global IV and Oral Iron Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global IV and Oral Iron Drugs Market Share by Regions (2022-2027)
Figure 16. Global IV and Oral Iron Drugs Market Share by Players in 2020
Figure 17. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IV and Oral Iron Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by IV and Oral Iron Drugs Revenue in 2020
Figure 19. Global IV and Oral Iron Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global IV and Oral Iron Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America IV and Oral Iron Drugs Market Share by Type (2016-2027)
Figure 23. North America IV and Oral Iron Drugs Market Share by Application (2016-2027)
Figure 24. North America IV and Oral Iron Drugs Market Share by Country (2016-2027)
Figure 25. United States IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe IV and Oral Iron Drugs Market Share by Type (2016-2027)
Figure 29. Europe IV and Oral Iron Drugs Market Share by Application (2016-2027)
Figure 30. Europe IV and Oral Iron Drugs Market Share by Country (2016-2027)
Figure 31. Germany IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific IV and Oral Iron Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific IV and Oral Iron Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific IV and Oral Iron Drugs Market Share by Region (2016-2027)
Figure 41. China IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America IV and Oral Iron Drugs Market Share by Type (2016-2027)
Figure 49. Latin America IV and Oral Iron Drugs Market Share by Application (2016-2027)
Figure 50. Latin America IV and Oral Iron Drugs Market Share by Country (2016-2027)
Figure 51. Mexico IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa IV and Oral Iron Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa IV and Oral Iron Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa IV and Oral Iron Drugs Market Share by Country (2016-2027)
Figure 57. Turkey IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE IV and Oral Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Daiichi Sankyo Company Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 61. Vifor Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 62. Akebia Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 64. AMAG Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 65. AOP Orphan Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 66. Pharmacosmos Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 68. Shield Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 69. AZAD Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 70. Cirondrugs Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 71. MEDICE Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 72. Pfizer Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 73. Salveo Lifecare Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 74. Sunny Pharmaceutical Revenue Growth Rate in IV and Oral Iron Drugs Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年）

Global Oral Anti-diabetes Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4619 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、経口抗糖尿病薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（液体、カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の掻痒治療薬市場規模・現状・予測（2021年-2027年）

Global Pruritus Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5973 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、掻痒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、非経口）、用途別市場規模（血液性そう痒症、腫瘍性そう痒症、腎性そう痒症、内分泌性そう痒症、胆汁うっ滞性そう痒症）、主要地域別市場規...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の女性用不妊治療薬市場規模・現状・予測（2021年-2027年）

Global Female Infertility Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5739 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、女性用不妊治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非経口、経口、その他）、用途別市場規模（卵巣過剰刺激症候群、多胎妊娠、多胎児、早産、低出生体重、帝王切開危険性）、主要地域別市場規模（北...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Non Insulin Anti diabetes Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4583 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、インスリン非依存型糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の腎臓薬市場規模・現状・予測（2021年-2027年）

Global Renal Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5990 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の貧血治療薬市場規模・現状・予測（2021年-2027年）

Global Anemia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3805 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤）、用途別市場規模（鉄欠乏性貧血、サラセミア、再生...

世界のヒトマイクロバイオーム治療薬市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Therapeutic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4332 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ヒトマイクロバイオーム治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム医薬品、その他）、用途別市場規模（胃、口腔、気道、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の肥満細胞腫治療薬市場規模・現状・予測（2021年-2027年）

Global Mast Cell Tumor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4463 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、肥満細胞腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用薬、経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …
口腔粘膜炎治療薬のグローバル市場2021 Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemoth…
世界の高血圧＆心不全治療薬市場規模・現状・予測（2021年-2027年） Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to c…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Immunostimulant Market The global Oral Immunostimulant market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…